Latest news
177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment - CancerNetworkCancerNetwork · Mon, 10 Aug 2026 19:53:51 GMTHow Investors Are Reacting To Replimune Group (REPL) FDA Accelerated Approval For New Melanoma Therapy - simplywall.stsimplywall.st · Mon, 10 Aug 2026 18:59:38 GMTREPL Stock Hits Near 18-Month High On Pricing Of $150M Offering – But, Retail Sees Share Price ‘Unwinding Over Time’ - TradingViewTradingView · Mon, 10 Aug 2026 16:21:20 GMTIn surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment - STATSTAT · Mon, 10 Aug 2026 15:13:53 GMTFDA approval of mFLUSIVA highlights Moderna’s position in mRNA market - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 15:02:41 GMTNew Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approval - U.S. News & World ReportU.S. News & World Report · Mon, 10 Aug 2026 14:58:00 GMTFDA Approves New Flu Shot Using COVID-Era Tech—Here’s Who Can Get It - NewsweekNewsweek · Mon, 10 Aug 2026 14:24:00 GMTNRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles - MarketBeatMarketBeat · Mon, 10 Aug 2026 14:19:54 GMT